PMH2 ANTIPSYCHOTIC USE PATTERNS AND HEALTHCARE COSTS FOR INDIVIDUALS WITH SCHIZOPHRENIA TREATED WITH HALOPERIDOL, OLANZAPINE OR RISPERIDONE IN A MEDICAID POPULATION
Abstract
Authors
JL Ramsey D Hutchins B Zhu Z Zhao PJ Gibson M Lothgren